Bio-Rad Laboratories, Inc. (BIO.B) stock
BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value
$379.50+0.00 (0.00%)
Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –
Bio-Rad Laboratories operating margin
Operating margin is operating income as a percentage of revenue.
Bio-Rad Laboratories's operating margin for the twelve months ending Jun 30, 2026 was 2.1%. For fiscal 2025 it was 1.8%, against 10.5% the year before. The highest annual figure on record is 17.2% in fiscal 2022.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.8% | −8.7 |
| FY2024 | Dec 31, 2024 | 10.5% | −2.2 |
| FY2023 | Dec 31, 2023 | 12.6% | −4.6 |
| FY2022 | Dec 31, 2022 | 17.2% | +0.1 |
| FY2021 | Dec 31, 2021 | 17.1% | +0.6 |
| FY2020 | Dec 31, 2020 | 16.6% | +6.6 |
| FY2019 | Dec 31, 2019 | 9.9% | +14.4 |
| FY2018 | Dec 31, 2018 | -4.5% | −10.0 |
| FY2017 | Dec 31, 2017 | 5.5% | +2.8 |
| FY2016 | Dec 31, 2016 | 2.7% | −5.6 |
| FY2015 | Dec 31, 2015 | 8.3% | +1.4 |
| FY2014 | Dec 31, 2014 | 6.9% | −1.0 |
| FY2013 | Dec 31, 2013 | 7.9% | −4.8 |
| FY2012 | Dec 31, 2012 | 12.8% | −2.0 |
| FY2011 | Dec 31, 2011 | 14.7% | −0.0 |
| FY2010 | Dec 31, 2010 | 14.7% | +1.8 |
| FY2009 | Dec 31, 2009 | 12.9% | +2.6 |
| FY2008 | Dec 31, 2008 | 10.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 11.2% | −0.7 |
| Q1 FY2026 | Mar 31, 2026 | 5.8% | +1.7 |
| Q4 FY2025 | Dec 31, 2025 | -17.2% | −25.9 |
| Q3 FY2025 | Sep 30, 2025 | 10.0% | +0.1 |
| Q2 FY2025 | Jun 30, 2025 | 11.8% | −4.1 |
| Q1 FY2025 | Mar 31, 2025 | 4.0% | −3.3 |
| Q4 FY2024 | Dec 31, 2024 | 8.7% | −5.3 |
| Q3 FY2024 | Sep 30, 2024 | 9.9% | −4.5 |
| Q2 FY2024 | Jun 30, 2024 | 15.9% | +2.7 |
| Q1 FY2024 | Mar 31, 2024 | 7.3% | −1.8 |
| Q4 FY2023 | Dec 31, 2023 | 14.0% | −2.3 |
| Q3 FY2023 | Sep 30, 2023 | 14.4% | +0.5 |
| Q2 FY2023 | Jun 30, 2023 | 13.2% | −4.6 |
| Q1 FY2023 | Mar 31, 2023 | 9.1% | −11.8 |
| Q4 FY2022 | Dec 31, 2022 | 16.2% | +0.2 |
| Q3 FY2022 | Sep 30, 2022 | 13.9% | −7.1 |
| Q2 FY2022 | Jun 30, 2022 | 17.8% | +0.4 |
| Q1 FY2022 | Mar 31, 2022 | 20.9% | +7.0 |
| Q4 FY2021 | Dec 31, 2021 | 16.1% | −7.4 |
| Q3 FY2021 | Sep 30, 2021 | 21.0% | +4.1 |
| Q2 FY2021 | Jun 30, 2021 | 17.4% | +7.8 |
| Q1 FY2021 | Mar 31, 2021 | 13.9% | +0.9 |
| Q4 FY2020 | Dec 31, 2020 | 23.5% | +14.0 |
| Q3 FY2020 | Sep 30, 2020 | 16.9% | +6.7 |
| Q2 FY2020 | Jun 30, 2020 | 9.6% | −0.2 |
| Q1 FY2020 | Mar 31, 2020 | 13.0% | +2.8 |
| Q4 FY2019 | Dec 31, 2019 | 9.5% | +46.3 |
| Q3 FY2019 | Sep 30, 2019 | 10.2% | +3.6 |
| Q2 FY2019 | Jun 30, 2019 | 9.8% | +2.2 |
| Q1 FY2019 | Mar 31, 2019 | 10.2% | +2.3 |
| Q4 FY2018 | Dec 31, 2018 | -36.8% | −44.2 |
| Q3 FY2018 | Sep 30, 2018 | 6.7% | −0.6 |
| Q2 FY2018 | Jun 30, 2018 | 7.6% | +7.9 |
| Q1 FY2018 | Mar 31, 2018 | 7.9% | +2.7 |
| Q4 FY2017 | Dec 31, 2017 | 7.4% | +12.3 |
| Q3 FY2017 | Sep 30, 2017 | 7.3% | +2.8 |
| Q2 FY2017 | Jun 30, 2017 | -0.3% | – |
| Q1 FY2017 | Mar 31, 2017 | 5.2% | – |
| Q4 FY2016 | Dec 31, 2016 | -4.9% | – |
| Q3 FY2016 | Sep 30, 2016 | 4.5% | – |